ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Administrative Data"

  • Abstract Number: 0723 • ACR Convergence 2024

    Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis

    Warren RG James1, Corri Black1, Neil Basu2, Mark A Little3 and Rosemary Hollick1, 1University of Aberdeen, Aberdeen, United Kingdom, 2University of Glasgow, Glasgow, Scotland, United Kingdom, 3Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Increasing evidence suggests that socioeconomic status drives differences in outcomes for people with rheumatic conditions. Individuals with complex, rare rheumatic conditions such as antineutrophil…
  • Abstract Number: 1868 • ACR Convergence 2024

    Opioid Prescription Rates in Patients with Radiographic Axial Spondyloarthritis in the US Between 2008-2021: A Joinpoint Regression Analysis

    Berk Degirmenci1, Christine Peloquin2, Sara Lodi1, Pedro M Machado3, S. Reza Jafarzadeh2, Tuhina Neogi2, Lianne S Gensler4, Maureen Dubreuil5 and Jean Liew2, 1Boston University, Boston, MA, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Department of Neuromuscular Diseases and Centre for Rheumatology, University College London, London, United Kingdom, 4Department of Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 5Section of Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: Current axial spondyloarthritis (axSpA) guidelines do not provide recommendations for opioids in pain management. Opioid use is common in axSpA, despite widespread uptake of…
  • Abstract Number: 0806 • ACR Convergence 2024

    Rotavirus Vaccine in Offspring Exposed to Tumour Necrosis Factor Inhibitors During the Third Trimester Does Not Increase Diarrhea-Associated Healthcare Events

    Leah K. Flatman1, Sasha Bernatsky2, Isabelle Malhamé3, Yvan St-Pierre4, Olga Basso1, Anick Bérard5 and Evelyne Vinet3, 1McGill University, Montreal, QC, Canada, 2Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4McGill University Health Center, Montreal, QC, Canada, 5Université de Montréal, Montreal, QC, Canada

    Background/Purpose: Until recently, best practice guidelines recommended withholding rotavirus vaccine in offspring exposed in utero to any TNFi until 6 months of age due to fears of…
  • Abstract Number: 1870 • ACR Convergence 2024

    Costs and Healthcare Resource Utilization Associated with Inpatient and Day Hospitalizations of Patients with Lupus and Psychiatric Manifestations in France

    Nicoleta Petrica1, Nathan Cohen1, Maria Pini1, Minjee Park2, Mathieu Rosé3 and Jean-Francois Ricci2, 1Alira Health, Paris, France, 2Alira Health, Basel, Switzerland, 3Alira Health, Barcelone, Spain

    Background/Purpose: Lupus, a rare chronic autoimmune disorder, severely impacts patients' quality of life, productivity, and survival, placing a heavy burden on the healthcare system. Up…
  • Abstract Number: 0980 • ACR Convergence 2024

    Ambient Air Pollution and Initiation of bDMARDs in Newly Diagnosed Rheumatoid Arthritis: A Nested Case-Control Study of NIH All of Us Cohort

    Jiayi Zheng1, Nevena Barjaktarovic2 and Liangjing lu3, 1Washington University School of Medicine, St. Louis, MO, 2The Wright Center for Community Health, South Abington Township, PA, 3Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (People's Republic)

    Background/Purpose: Ambient air pollution is a mixture of solid particles and gaseous pollutants derived from fossil fuel combustion and vehicle exhaust. Previous research has linked…
  • Abstract Number: 1893 • ACR Convergence 2024

    Hydroxychloroquine Use in Early Pregnancy and Risk of Preterm Delivery in a Californian Cohort of Lupus Pregnancy

    Amadeia Rector1, Emily Liu2, Miranda Cantu3, Eliza Chakravarty4, Maurice Druzin5, Gary Shaw6, Michael Weisman7, Monique Hedderson2 and Julia Simard8, 1Stanford University, San Francisco, CA, 2Kaiser Permanente Division of Research, Oakland, CA, 3Patient partner, Portage, MI, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Stanford University School of Medicine, Stanford, CA, 6Stanford University School of Medicine, Stanford, 7Stanford University, Los Angeles, CA, 8Stanford School of Medicine, Stanford, CA

    Background/Purpose: Preterm delivery (PTD) occurs 2-3 times more frequently in patients with systemic lupus erythematosus (SLE) compared to the general obstetric population. Hydroxychloroquine (HCQ), a…
  • Abstract Number: 1011 • ACR Convergence 2024

    Use of the Shingrix Vaccine Among Patients with Inflammatory Arthritis and Risk of Cardiovascular Events Following Herpes Zoster

    Jeffrey Curtis1, Danielle M Conrad2, Whitney S Krueger2, Andrew P Gara2 and Kevin Winthrop3, 1FASTER Medicine, Hoover, AL, 2AbbVie, North Chicago, IL, 3School of Medicine, Oregon Health and Science University, Portland, OR

    Background/Purpose: The risk of herpes zoster (HZ) is increased in patients with inflammatory arthritis (IA); although the Shingrix vaccine has been available since 2017, its…
  • Abstract Number: 1911 • ACR Convergence 2024

    Improving Healthcare Access in Underserved Brooklyn Communities: A Comprehensive Multispecialty Patient Navigator Program

    Meenakshi Kurup1, Grace Shadid2, Jasmine Pak2, Alejandra Moncayo3, Naureen Kabani4, Soodeh Kabir5, Sharon Glick5 and Ellen Ginzler6, 1SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY, 2SUNY Downstate College of Medicine, Brooklyn, NY, 3SUNY Downstate Health Sciences University, College of Medicine, Brooklyn, NY, 4SUNY Downstate Medical Center, Brooklyn, NY, 5SUNY Downstate Health Sciences University, Department of Dermatology, Brooklyn, NY, 6SUNY Downstate Health Sciences University, New York, NY

    Background/Purpose: Underserved communities in the USA face significant healthcare disparities, leading to poorer clinical outcomes and higher rates of chronic diseases. Socioeconomic barriers such as…
  • Abstract Number: 0805 • ACR Convergence 2023

    De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis

    Jiha Lee1, Navasuja Kumar1, Mohammed Kabeto1, Andrzej Galecki1, Chiang-Hua Chang1, Namrata Singh2, Raymond Yung3, Una Makris4 and Julie Bynum1, 1University of Michigan, Ann Arbor, MI, 2University of Washington, Bellevue, WA, 3Michigan Medicine, Ann Arbor, MI, 4UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Biologic disease modifying anti-rheumatic drugs (bDMARDs) such as anti-tumor necrosis factors(anti-TNFs) improve clinical and radiographic outcomes in rheumatoid arthritis (RA). However, their use is…
  • Abstract Number: 1199 • ACR Convergence 2023

    Association of Dipeptidyl Peptidase-4 Inhibitor Use for Type 2 Diabetes and Incidence of OA in Taiwan

    Hsiang-Yen Lee1, Ching-Kuei Chang1, Tzu-Min Lin1, Tzu-Tung Ku2, Jin-Hua Chen2, Yu-Hsiu Chen3, Shu-Chuan Chen4 and Chi-Ching Chang2, 1Taipei Medical University Hospital, Taipei, Taiwan, 2Taipei Medical University, Taipei, Taiwan, 3Tri-Service General Hospital, Taipei, Taiwan, 4Idaho State University, Idaho State Pocatello, ID

    Background/Purpose: Cellular senescence is involved in osteoarthritis (OA) development. Dipeptidyl Peptidase-4 (DPP4) is associated with senescence in OA chondrocytes. It is uncertain whether DPP4 inhibitor…
  • Abstract Number: 2460 • ACR Convergence 2023

    Health Care Segregation, but Not Metropolitan Area Segregation, Magnifies Racial Disparities in Hospital Outcomes of Pediatric Lupus

    Joyce Chang1, Jessica Liu1, Laura Berbert1, Edie Weller1, Gabrielle Alonzi1, Emily Smitherman2, Pooja Patel3, Mary Beth Son4 and Karen Costenbader5, 1Boston Children's Hospital, Boston, MA, 2University of Alabama at Birmingham, Birmingham, AL, 3Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4Division of Immunology, Boston Children's Hospital, Boston, MA, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Racial disparities and hospital-level variation in pediatric SLE (pSLE) outcomes are well described, but it is not known how the racial and ethnic composition…
  • Abstract Number: 0807 • ACR Convergence 2023

    Inferring Disease Activity Scores and Low Disease Activity at Registry Visits Based on Structured and Narrative Data from Electronic Health Records

    David Cheng1, Dana Weisenfeld2, Kumar Dahal2, Qing Liu2, Vidul Ayakulangara Panickan3, Mary Jeffway2, Thany Seyok2, Gregory McDermott2, Michael Weinblatt4, Nancy Shadick5, Tianxi Cai6 and Katherine Liao2, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Harvard Medical School, Boston, MA, 4Harvard Medical School, Waban, MA, 5Brigham and Women's Hospital, Boston, MA, 6Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: Real-world data including electronic health records (EHRs) are a promising resource for learning to optimize treatment strategies for rheumatoid arthritis (RA). A major challenge…
  • Abstract Number: 1275 • ACR Convergence 2023

    Prevalence of Frailty Among Individuals Living with Rheumatoid Arthritis: A Population-based Cohort Study

    Alexandra Legge1 and Diane Lacaille2, 1Dalhousie University, Halifax, NS, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Studies have demonstrated a link between frailty and chronic inflammation, raising the question of whether chronic inflammatory diseases like rheumatoid arthritis (RA) may be…
  • Abstract Number: 2522 • ACR Convergence 2023

    Diabetes Mellitus Impacts Primary Total Hip Arthroplasty Outcomes: A National Cohort Study

    Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

    Background/Purpose: Primary total hip arthroplasty (THA) patients often have concomitant medical comorbidities. This study aims to identify the impact of diabetes mellitus (DM) on inpatient…
  • Abstract Number: 0811 • ACR Convergence 2023

    Comparative Effectiveness of Sodium-glucose cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-primary Emergency Department Visits and Hospitalizations: A General Population Cohort Study

    Natalie McCormick1, Chio Yokose2, Jie Wei3, Na Lu4, Deborah Wexler1, Mary De Vera5, J. Antonio Avina-Zubieta4, Yuqing Zhang6 and Hyon K. Choi7, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Health Management Center, Xiangya Hospital Central South University, Changsha, China, 4Arthritis Research Canada, Vancouver, BC, Canada, 5University of British Columbia, Vancouver, BC, Canada, 6Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 7Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) lower serum urate (primary prevention); however, whether this translates into preventing recurrent flares among gout patients (secondary prevention) and gout-primary…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology